@microdoseHQ
The Third Wave Virtual Summit: Coaching and the New Psychedelic Paradigm
The Third Wave Virtual Summit: Coaching and the New Psychedelic Paradigm
MindMed Receives 700% Price Target From Roth Capital
MindMed Receives 700% Price Target From Roth Capital
Roth Capital Partners has initiated coverage on MindMed with a $7 price target, over 700% the current stock price.
MindMed Files For $200 Million Raise
MindMed Files For $200 Million Raise
For an in-depth exploration of psychedelics, take the Science of Psychedelics course
For an in-depth exploration of psychedelics, take the Science of Psychedelics course
Help TheraPsil-Supported Patients and Clinicians Fight for Legal Psilocybin
Help TheraPsil-Supported Patients and Clinicians Fight for Legal Psilocybin
GET TICKETS TO WONDERLAND
GET TICKETS TO WONDERLAND
Activists Protest the DEA for Psilocybin Access
Activists Protest the DEA for Psilocybin Access
Entheogens: A Look at Modern Culture and History
Entheogens: A Look at Modern Culture and History
Psychedelic Reform and Decrim Update
Psychedelic Reform and Decrim Update
Nue Life Closes $23 million Series A Financing
Nue Life Closes $23 million Series A Financing
MindMed to Announce Results for LSD Trial
MindMed to Announce Results for LSD Trial
Today we learned that MindMed collaborators from the University Hospital Basel will present results from their Phase 2 clinical trial of LSD in the treatment of anxiety disorders.
New Study Shows Psilocybin Rewires Brain After Depression
New Study Shows Psilocybin Rewires Brain After Depression
Numinus Wellness to Acquire Novamind
Numinus Wellness to Acquire Novamind
Christian Angermayer Buys 1 Million Shares of ATAI
Christian Angermayer Buys 1 Million Shares of ATAI
Psychedelic medicine is a long-term play and atai founder Christian Angermayer has just given us a multi-million dollar reminder
Entheogenic Culture and History
Entheogenic Culture and History
Field Trip Granted Patent for Lead Compound FT-104
Field Trip Granted Patent for Lead Compound FT-104
MindMed Reports 2021 Financial and Business Results
MindMed Reports 2021 Financial and Business Results
Connecting to Nature Through Psychedelics
Connecting to Nature Through Psychedelics
Extending the Experience: Interview with DMT Pioneer Rick Strassman
Extending the Experience: Interview with DMT Pioneer Rick Strassman
ATAI Announces Fourth Quarter and Full Year 2021 Results
ATAI Announces Fourth Quarter and Full Year 2021 Results
Oregon Pushes for Spiritual Psilocybin Use
Oregon Pushes for Spiritual Psilocybin Use
Announcing Microdose X
Announcing Microdose X
Join us at Wonderland Miami on Nov 14-16, 2022
Join us at Wonderland Miami on Nov 14-16, 2022
Watch the Wonderland Miami 2021 digital recordings
Watch the Wonderland Miami 2021 digital recordings
Watch recordings from past events (Psychedelic Capital & more)
Watch recordings from past events (Psychedelic Capital & more)
Read: Cathie Wood and ARK Increase Support for Psychedelics
Read: Cathie Wood and ARK Increase Support for Psychedelics
Read: A Deeper Look at DMT
Read: A Deeper Look at DMT
Read: Johns Hopkins Study Shows Psilocybin Effective for a Year
Read: Johns Hopkins Study Shows Psilocybin Effective for a Year
Join Microdose Slack
Join Microdose Slack
Chat with Our Team
Chat with Our Team
Website
Website
View on mobile
